Donor Cardiac Troponin I Levels Do Not Predict Recipient Survival After Cardiac Transplantation

Journal of Heart and Lung Transplantation

Volumn 26, Issue 10, 2007, Pages 1048-1053

  Khush, Kiran K ^a   Menza, Rebecca L ^b   Babcock, Wayne D ^b   Zaroff, Jonathan G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b California Transplant Donor Network   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; INOTROPIC AGENT; METHYLPREDNISOLONE; PHENYLEPHRINE; TROPONIN I;

ADULT; ARTICLE; ASSISTED CIRCULATION; DRUG MEGADOSE; EVALUATION; FEMALE; HEART TRANSPLANTATION; HEMODYNAMICS; HOSPITALIZATION; HUMAN; HUMAN EXPERIMENT; MALE; MORTALITY; NORMAL HUMAN; ORGAN DONOR; OUTCOME ASSESSMENT; PATIENT SAFETY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESUSCITATION; RISK ASSESSMENT; SURVIVAL RATE; UNITED STATES;

ADOLESCENT; ADULT; FEMALE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TROPONIN I;

EID: 34848852939     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.07.026     Document Type: Article

References (22)

1. Potapov E.V., Ivanitskaia E.A., Loebe M., et al. Value of cardiac troponin I and T for selection of heart donors and as predictors of early graft failure. Transplantation 71 (2001) 1394-1400
2. Deibert E., Aiyagari V., and Diringer M.N. Reversible left ventricular dysfunction associated with raised troponin I after subarachnoid haemorrhage does not preclude successful heart transplantation. Heart 84 (2000) 205-207
3. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report--2005. J Heart Lung Transplant 24 (2005) 945-955
4. Costanzo M.R., Augustine S., Bourge R., et al. Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 92 (1995) 3593-3612
5. Gridelli B., and Remuzzi G. Strategies for making more organs available for transplantation. N Engl J Med 343 (2000) 404-410
6. Mokadam N.A., Ewald G.A., Damiano Jr. R.J., and Moazami N. Deterioration and mortality among patients with United Network for Organ Sharing status 2 heart disease: caution must be exercised in diverting organs. J Thorac Cardiovasc Surg 131 (2006) 925-926
7. Zimmermann R., Baki S., Dengler T.J., et al. Troponin T release after heart transplantation. Br Heart J 69 (1993) 395-398
8. Young J.B., Naftel D.C., Bourge R.C., et al. Matching the heart donor and heart transplant recipient. Clues for successful expansion of the donor pool: a multivariable, multiinstitutional report. The Cardiac Transplant Research Database Group. J Heart Lung Transplant 13 (1994) 353-364 discussion 364-5
9. Hosenpud J.D., Novick R.J., Breen T.J., Keck B., and Daily P. The Registry of the International Society for Heart and Lung Transplantation: twelfth official report--1995. J Heart Lung Transplant 14 (1995) 805-815
10. Christenson R.H., Duh S.H., Newby L.K., et al. Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators. Clin Chem 44 (1998) 494-501
11. Stubbs P., and Collinson P. Cardiac troponins in acute coronary syndromes. N Engl J Med 336 (1997) 1257-1258 author reply 1258-9
12. Zaroff J.G., Babcock W.D., Shiboski S.C., Solinger L.L., and Rosengard B.R. Temporal changes in left ventricular systolic function in heart donors: results of serial echocardiography. J Heart Lung Transplant 22 (2003) 383-388
13. Wheeldon D.R., Potter C.D., Oduro A., Wallwork J., and Large S.R. Transforming the "unacceptable" donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant 14 (1995) 734-742
14. Szabo G., Hackert T., Sebening C., Vahl C.F., and Hagl S. Modulation of coronary perfusion pressure can reverse cardiac dysfunction after brain death. Ann Thorac Surg 67 (1999) 18-25 discussion 25-6
15. Mayer S.A., LiMandri G., Sherman D., et al. Electrocardiographic markers of abnormal left ventricular wall motion in acute subarachnoid hemorrhage. J Neurosurg 83 (1995) 889-896
16. Seiler C., Laske A., Gallino A., Turina M., and Jenni R. Echocardiographic evaluation of left ventricular wall motion before and after heart transplantation. J Heart Lung Transplant 11 (1992) 867-874
17. Zaroff J.G., Rosengard B.R., Armstrong W.F., et al. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va. Circulation 106 (2002) 836-841
18. Kono T., Nishina T., Morita H., Hirota Y., Kawamura K., and Fujiwara A. Usefulness of low-dose dobutamine stress echocardiography for evaluating reversibility of brain death-induced myocardial dysfunction. Am J Cardiol 84 (1999) 578-582
19. Milano A., Livi U., Casula R., et al. Influence of marginal donors on early results after heart transplantation. Transplant Proc 25 (1993) 3158-3159
20. Riou B., Dreux S., Roche S., et al. Circulating cardiac troponin T in potential heart transplant donors. Circulation 92 (1995) 409-414
21. Vijay P., Scavo V.A., Morelock R.J., Sharp T.G., and Brown J.W. Donor cardiac troponin T: a marker to predict heart transplant rejection. Ann Thorac Surg 66 (1998) 1934-1939
22. Miller W.L., Edwards B.S., Kremers W.K., et al. Elevated donor troponin levels are associated with a lower frequency of allograft vasculopathy. J Heart Lung Transplant 24 (2005) 2075-2078